Abstract
Patients taking oral contraceptive steroids (OCS) are known to suffer contraceptive failure while taking anticonvulsants such as phenobarbitone, phenytoin and carbamazepine. We have studied the single dose kinetics of ethinyloestradiol (EE2); 50 micrograms, and levonorgestrel (Ng); 250 micrograms in groups of women before and 8-12 weeks after starting therapy with phenytoin (n = 6) and carbamazepine (n = 4). The area under the plasma concentration-time curve (AUC) was measured over a 24 h period for each steroid and significant reductions were seen with both anticonvulsants. Phenytoin reduced the AUC for EE2 from 806 +/- 50 (mean +/- s.d.) to 411 +/- 132 pg ml-1 h (P less than 0.05) and for Ng from 33.6 +/- 7.8 to 19.5 +/- 3.8 ng ml-1 h (P less than 0.05). Carbamazepine reduced the AUC for EE2 from 1163 +/- 466 to 672 +/- 211 pg ml-1 h (P less than 0.05) and for Ng from 22.9 +/- 9.4 to 13.8 +/- 5.8 ng ml-1 h (P less than 0.05). These changes are compatible with the known enzyme inducing effects of phenytoin and carbamazepine. Patients taking these anticonvulsants will need to be given increased doses of OCS (equivalent to 50-100 micrograms EE2 daily) to achieve adequate contraceptive effects.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Back D. J., Bates M., Bowden A., Breckenridge A. M., Hall M. J., Jones H., MacIver M., Orme M., Perucca E., Richens A. The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy. Contraception. 1980 Nov;22(5):495–503. doi: 10.1016/0010-7824(80)90102-x. [DOI] [PubMed] [Google Scholar]
- Back D. J., Bates M., Breckenridge A. M., Hall J. M., MacIver M., Orme M. L., Park B. K., Rowe P. H. The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette. Contraception. 1981 Mar;23(3):229–239. doi: 10.1016/0010-7824(81)90045-7. [DOI] [PubMed] [Google Scholar]
- Back D. J., Breckenridge A. M., Crawford F. E., MacIver M., Orme M. L., Rowe P. H., Watts M. J. An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay. Contraception. 1979 Sep;20(3):263–273. doi: 10.1016/0010-7824(79)90098-2. [DOI] [PubMed] [Google Scholar]
- Back D. J., Grimmer S. F., Orme M. L., Proudlove C., Mann R. D., Breckenridge A. M. Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics. Br J Clin Pharmacol. 1988 May;25(5):527–532. doi: 10.1111/j.1365-2125.1988.tb03341.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
- Coulam C. B., Annegers J. F. Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia. 1979 Oct;20(5):519–525. doi: 10.1111/j.1528-1157.1979.tb04834.x. [DOI] [PubMed] [Google Scholar]
- Crawford P., Chadwick D., Cleland P., Tjia J., Cowie A., Back D. J., Orme M. L. The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids. Contraception. 1986 Jan;33(1):23–29. doi: 10.1016/0010-7824(86)90028-4. [DOI] [PubMed] [Google Scholar]
- Kenyon I. E. Unplanned pregnancy in an epileptic. Br Med J. 1972 Mar 11;1(5801):686–687. doi: 10.1136/bmj.1.5801.686-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Orme M. L., Back D. J., Breckenridge A. M. Clinical pharmacokinetics of oral contraceptive steroids. Clin Pharmacokinet. 1983 Mar-Apr;8(2):95–136. doi: 10.2165/00003088-198308020-00001. [DOI] [PubMed] [Google Scholar]
- Park B. K., Breckenridge A. M. Clinical implications of enzyme induction and enzyme inhibition. Clin Pharmacokinet. 1981 Jan-Feb;6(1):1–24. doi: 10.2165/00003088-198106010-00001. [DOI] [PubMed] [Google Scholar]